Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Subscribe To Our Newsletter
SHORT ITEMS
GFO Issue 9

SHORT ITEMS

Author:

Bernard Rivers

Article Type:
News

Article Number: 6

ABSTRACT The Fund has announced an RFP for Local Fund Agents, and an appeals procedure is available for a limited number of applicants who were rejected in both Round 1 and Round 2.

The Fund has announced a “Request for Proposals” for Local Fund Agents (LFAs). As explained in detail at www.globalfundatm.org/rfp, the Fund intends to award a number of “Local Fund Agent Framework Contracts” for its worldwide operations, from which country-specific work orders will be issued. The Fund “will view favorably proposals that coordinate services across multiple countries, but will also consider high-quality proposals for single countries.” The deadline for proposal submission is 27 June. An information session will take place in Geneva on 19 May.

The Fund has instituted an Internal Appeal Mechanism which allows applicants whose proposals were rejected in two consecutive rounds to appeal the second decision. Details are available at www.globalfundatm.org/proposals.html, which states, “An Internal Appeal may be made only if it is based on a significant and obvious error made by the TRP regarding the information contained in the second proposal. No new information or new justification to what was contained in the second proposal may be introduced in an Internal Appeal.” All applicants to whom this procedure is applicable should already have been informed of this mechanism. Appeals must be received by the Fund within four weeks of receipt of notice of the mechanism. Applicants using the appeals mechanism are not allowed to submit a new proposal for the same disease while their appeal is under review. This is to avoid a situation where essentially the same proposal might be approved twice. The deadline for Round 3 is, however, set a few days after the appeals process is supposed to be concluded. This gives applicants who may be unsuccessful with their appeal the chance to submit a revised proposal for Round 3.

Doctors Without Borders/Médecins Sans Frontières (MSF) has just released the latest quarterly update of “Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries.” (See www.accessmed-msf.org/documents/untangling4thapril2003.pdf) Although the publication date is shown as April 24th, the document includes the new GlaxoSmithKline prices that were announced last week. French and Spanish versions should be ready within a few days. The document will be included as an annex to the WHO-MSF-UNICEF-UNAIDS document “Sources and prices of selected medicines and diagnostics for people living with HIV/AIDS, May 2003,” which will be released shortly.

Leave a reply

  • Anonymous comments (0)
  • Facebook Comments

Your email address will not be published.

Aidspan

Categories*

Loading
Aidspan

Categories*

Loading